Background Flashcards
What is the estimated annual incidence of penile cancer in the United States? What % of male cancers does this represent?
There are ∼2,000 new cases/yr of penile cancer in the United States, representing <1% of male cancers. In developing countries, it can account for up to 10% of all male cancers.
What are the major risk factors for developing penile cancer?
Risk factors for penile cancer:
Lack of circumcision
Phimosis
HPV infection (45%–80% of cases are related)
HIV infection
Others risk factors include: chronic inflammation, poor hygiene, trauma, lichen sclerosus, smoking, and PUVA therapy.
What is penile intraepithelial neoplasia (PeIN)?
PeIN is a premalignant condition at high risk of developing into SCC of the penis and includes bowenoid papulosis, erythroplasia of Queyrat (glans and prepuce), and Bowen Dz (penile shaft).
What are the 2 most common anatomic locations for penile cancer?
The glans and prepuce are the 2 most common locations for penile cancer. Less common locations include the coronal sulcus and the shaft. Lesions can appear as a mass, ulceration, or inflammation.
What is the lymphatic drainage for penile cancers?
Superficial inguinal nodes → deep inguinal nodes → external iliac nodes → other pelvic nodes
What % of men with penile cancer and palpable inguinal nodes have pathologically involved inguinal nodes?
Overall, ∼58% of palpable inguinal nodes in pts with penile cancer are pathologically involved.
What is the likelihood of occult nodal Dz in men who are cN0?
The likelihood of occult nodal involvement depends on the tumor stage, grade, and presence of LVI. It is 4%–14% for Tis, Ta, or T1 lesions and 60% for T2 lesions.
What % of men with penile cancer present with DM?
1%–10% present with DM.
What are the most common sites for DM in penile cancer?
Lung, liver, and bone are the most common sites for DM in penile cancer.
What is the most common histology in penile cancer?
SCC accounts for 95% of penile malignancies. Other histologic subtypes include sarcoma, urethral tumors, lymphoma, and basal cell carcinoma.